Skip to main content
. 2021 Nov 18;13:135. doi: 10.1186/s13098-021-00756-y

Table 1.

Baseline information of male patients with HIV (n = 61)

Variable χ ± SD or cases (%) Range
Age (years) 32.05 ± 8.38 20–58
Gender (male, %) 61 (100%)
Infection duration (months) 11.16 ± 1.19 1–86
T lymphocyte subsets
 CD3+ count (cells/µL) 1433.98 ± 595.35 470–3074
 CD3+CD4+ count (cells/µL) 313.87 ± 118.473 54–499
 CD3+CD4+ percentage (%) 19.78 ± 6.83 1.40–43.40
 CD3+CD8+ count (cells/µL) 1119.70 ± 605.0 360–2456
 CD3+CD8+ percentage (%) 69.97 ± 13.80 36.13–97.20
 Virus load of HIVRNAa 41772.77 ± 10.38 895.00–505987.00
Metabolic parameters
 TG (mmol/L) 1.68 ± 1.23 0.39–16.81
 TC (mmol/L) 4.20 ± 0.72 2.38–6.09
 LDL-c (mmol/L) 2.61 ± 0.68 0.92–4.71
 HDL-c (mmol/L) 1.12 ± 0.24 0.57–1.77
 UA (µmol/L) 310.72 ± 68.65 143–506
Anthropometric parameters
 Body weight (kg) 62.41 ± 10.53 46–85
 Body mass index (kg/m2) 21.38 ± 2.82 16.80–28.20
 Body fat percentage (%) 15.99 ± 6.32 3–28.4
 Body fat weight (kg) 10.40 ± 5.33 1.4–22.10
 Body nonfat weight (kg) 51.82 ± 6.67 35.8–64.7
 Baseline body mass status
 Body mass index<18 kg/m2 3 (4.92)
 24 kg/m2 ≥ Body mass index ≥ 18 kg/m2 49 (80.33)
 Body mass index > 24 kg/m2 9 (14.75)

TG, triglyceride; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; UA, uric acid

aLogarithmic transformation before statistical analysis for nonnormally distributed data